Anocca logo

Anocca

Anocca is an individualized tcr and antigen cancer treatment founded in 2014.

2

Funding Rounds

$47.0m

Money raised

Overview

Anocca is an individualized tcr and antigen cancer treatment founded in 2014.

Funding

Funding series

Funding Series Analysis

The company Anocca has raised a total of $74m in funding over 2 rounds.

Key Insights:

  • Anocca December 2022 Debt Funding Round: $27m
  • Anocca Series B round, July 2021: $47m
Anocca logo
Anocca December 2022 Debt Funding Round $27m
Anocca logo
Anocca Series B round, July 2021 $47m